Interferon-α as an Effective Treatment for Noninfectious Posterior Uveitis and Panuveitis

IFN-α seems to have significant potential in treatment of severe, sight-threatening refractory uveitis from a variety of causes. A range of adverse events, including IFN-α-associated retinopathy, may occur and could limit the use of this immunomodulatory drug.